Request Demo
Last update 20 Mar 2025
NPC-21
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms fiztasovimab |
Target |
Action antagonists |
Mechanism CMV gB antagonists(CMV gB antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 1656510H
Source: *****
Sequence Code 1656517L
Source: *****
Related
1
Clinical Trials associated with NPC-21NCT04225923
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection
100 Clinical Results associated with NPC-21
Login to view more data
100 Translational Medicine associated with NPC-21
Login to view more data
100 Patents (Medical) associated with NPC-21
Login to view more data
100 Deals associated with NPC-21
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cytomegalovirus Infections | Phase 2 | Japan | 01 Jun 2020 | |
| Cytomegalovirus Infections | Phase 2 | United States | 01 Jun 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 87 | (NPC-21 Low Dose) | cjeghggoxn(imgapiabnt) = xawlybgnuu ppcmrxkpob (aeckdelpyz, wvmjqjiksm - jxlzcghlyd) View more | - | 28 Jun 2024 | ||
(NPC-21 High Dose) | cjeghggoxn(imgapiabnt) = ctodsqzvpm ppcmrxkpob (aeckdelpyz, rlzcqoyusp - dbjhmsygik) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free